Prospective Clinical Trial - Obturator Reflex Predictors and Blockage
NCT02228330 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-10-17
Summary
The aim of this study is to estimate the incidence rate of obturator nerve reflex and leg jerking during Transurethral Resections of Bladder Tumors (TURBTs), evaluate the efficacy of obturator nerve block in the prevention of inadvertent muscle spasm, and to identify predictors for both the jerking reflex and successful nerve block.
Conditions
- Malignant Neoplasm of Urinary Bladder
Interventions
- PROCEDURE
-
obturator nerve block
a uni-lateral obturator nerve block will be performed under ultrasound guidance- using 2% lidocaine for obtaining a short term block.
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
David Margel, MD, PhD · Rabin Medical Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2018-10-31
- Completion
- 2018-10-31
Countries
- Israel
Study Locations
More Related Trials
-
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT02845323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)
NCT04876313 ·Status: UNKNOWN ·Phase: PHASE2
-
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
NCT00045630 ·Status: COMPLETED ·Phase: PHASE2
-
Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals
NCT02538809 ·Status: TERMINATED
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2
-
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
NCT05223491 ·Status: COMPLETED ·Phase: NA
-
Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery
NCT02178241 ·Status: COMPLETED ·Phase: PHASE2
-
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
NCT04235764 ·Status: RECRUITING
-
Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)
NCT03230201 ·Status: UNKNOWN ·Phase: NA
-
Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
NCT07008833 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
NCT06324058 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Multicentric Evaluation of a Bladder Preservation Strategy
NCT01093066 ·Status: TERMINATED ·Phase: PHASE2
-
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
NCT06682728 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident
NCT03148158 ·Status: UNKNOWN
-
Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer
NCT06818799 ·Status: COMPLETED ·Phase: NA
-
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
NCT07322263 ·Status: RECRUITING ·Phase: PHASE2
-
Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer
NCT02688348 ·Status: WITHDRAWN ·Phase: NA
-
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
NCT02690558 ·Status: COMPLETED ·Phase: PHASE2
-
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
NCT02992990 ·Status: UNKNOWN ·Phase: NA
-
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
NCT06228066 ·Status: RECRUITING ·Phase: PHASE2
-
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
NCT02944357 ·Status: WITHDRAWN ·Phase: NA
-
Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors
NCT03238664 ·Status: WITHDRAWN ·Phase: NA
-
Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer
NCT05822934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT04688931 ·Status: TERMINATED ·Phase: PHASE3
-
Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection
NCT02202044 ·Status: TERMINATED ·Phase: NA